BAVENCIO
avelumab
Listed by EMD Serono, Inc.
- Strength
- 20 mg/mL
- Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Class
- Programmed Death Ligand-1 Blocker
What it contains
- Avelumab 20 mg/mL
FDA record
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Programmed Death Ligand-1 Blocker |
| Approval route | BLA — biologic licence |
| NDC code | 44087-3535 |
| FDA application | BLA761049 |
| RxNorm concept | 1875542 |
| Package sizes listed | 1 |
| Marketed since | March 2017 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.